Savvy Advisors Inc’s AbbVie ABBV Stock Holding History

Savvy Advisors Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.69M	Buy	44,558 +7,990	+22%	+$1.77M	0.26%	75
2025 Q4	$8.36M	Buy	36,568 +6,646	+22%	+$1.51M	0.27%	65
2025 Q3	$6.93M	Buy	29,922 +5,236	+21%	+$1.07M	0.32%	61
2025 Q2	$4.58M	Buy	24,686 +4,450	+22%	+$827K	0.31%	58
2025 Q1	$4.24M	Buy	20,236 +2,508	+14%	+$488K	0.43%	44
2024 Q4	$3.15M	Buy	17,728 +8,140	+85%	+$1.5M	0.38%	46
2024 Q3	$1.89M	Buy	9,588 +3,595	+60%	+$671K	0.38%	57
2024 Q2	$1.03M	Buy	5,993 +2,352	+65%	+$390K	0.34%	69
2024 Q1	$663K	Buy	3,641 +1,346	+59%	+$232K	0.38%	69
2023 Q4	$356K	Buy	+2,295	New	+$335K	0.35%	88

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Savvy Advisors Inc's ABBV Position: Q1 2026 in Review

Savvy Advisors Inc increased its AbbVie (ABBV) stake by 22% in Q1 2026, buying an estimated $1.77M and bringing the position to 44,558 shares worth $9.69M. The position accounts for 0.26% of the portfolio, ranked #75.

Savvy Advisors Inc first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Savvy Advisors Inc held 44,558 shares of AbbVie worth $9.69M as of Q1 2026.
Savvy Advisors Inc bought 7,990 AbbVie shares in Q1 2026, an estimated $1.77M.
AbbVie made up 0.26% of Savvy Advisors Inc's portfolio in Q1 2026, its #75 holding.
Savvy Advisors Inc first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Savvy Advisors Inc's 13F filing for Q1 2026, filed 11 May 2026.